An Observation study of Thymoglobuline as Induction therapy in a steriod free maintenance immuno-supressive protocol for INDIAN patients undergoing live donor renal transplantation - OTIS-INDIA.
Latest Information Update: 03 Jul 2019
Price :
$35 *
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Transplant rejection
- Focus Therapeutic Use
- Acronyms OTIS-INDIA
- 21 Mar 2012 Official title amended as reported by Clinical Trials Registry - India.
- 27 Sep 2011 New trial record